The EPNextS Group is committed to transforming international collaborative trials. As a total solution provider, we empower companies to expand international drug development from Japan to the world, and from the West into Japan and Asia. Not only do we support almost all major global pharmaceutical companies, but we also actively support biotech companies that generate pharmaceuticals using state-of-the-art technologies. Our global alliances with leading clinical trial companies ensure the continuous promotion of rapid and efficient drug development.